Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank
Claudia Pisanu, Nike Zoe Welander, Gull Rukh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112234-112234
Open Access | Times Cited: 11

Showing 11 citing articles:

Use of Acid-Suppression Therapy and Odds of Migraine and Severe Headache in the National Health and Nutrition Examination Survey
Margaret Slavin, Cara L. Frankenfeld, Alexander B. Guirguis, et al.
Neurology Clinical Practice (2024) Vol. 14, Iss. 3
Closed Access | Times Cited: 6
Migraine and its major subtypes – with and without aura are associated with polygenic scores for autism
Salahuddin Mohammad, Giorgia Bussu, Gull Rukh, et al.
Cephalalgia (2025) Vol. 45, Iss. 1
Closed Access
Effects of proton pump inhibitor (PPI) use on migraine – a critical review
Viktoria Tischler-Strasser, Irma Burdiladze, Gonçalo Cabral, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Association between CYP2C19 polymorphism and proton pump inhibitors adverse drug reactions: a narrative review
Ibrahim Aa, Kazeem B. Yusuff, Ahmed Awaisu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Association between proton pump inhibitor use and migraine: a systematic review and meta-analysis
Prakasini Satapathy, Mahalaqua Nazli Khatib, Nasir Vadia, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Antidepressant non-refill as a Proxy Measure for Medication Acceptability in Electronic Health Records
Jorge A. Sánchez-Ruiz, Melissa Solares-Bravo, Gregory D. Jenkins, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
A fresh look at proton pump inhibitor (PPI)-associated adverse events through a CYP2C19 pharmacogenetic lens
Rachel Chevalier, Thomas M. Attard, Sara L. Van Driest, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 2, pp. 53-56
Closed Access | Times Cited: 5
The Role of Gender Pharmacogenetics in the Personalization of Drug Treatment
Erika Cecchin, Bianca Posocco, Silvia Mezzalira, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 386, Iss. 2, pp. 190-197
Open Access | Times Cited: 5
Long-term exposure to air pollutants and new-onset migraine: A large prospective cohort study
Haojian Dong, Peng Ran, Dan‐Qing Liao, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 273, pp. 116163-116163
Open Access | Times Cited: 1
Association between Migraines and Prior Proton Pump Inhibitor Use: A Nested Case-Control Study Using a National Health Screening Cohort
Hojeong Kang, So Young Kim, Ji Hee Kim, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1385-1385
Open Access | Times Cited: 7
New Daily Persistent Headaches with Migrainous Features Following Proton Pump Inhibitor Use: A Case Report and Literature Review
Amir Soheil Tolebeyan
(2024)
Open Access
Page 1

Scroll to top